FDA authorizes expanded use of medical abortion pill Mifeprex
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Wednesday approved a request by Danco Laboratories to expand authorized use of its abortion pill Mifeprex, formerly known as RU-486, to 70 days of gestation from 49 days.
Aucun commentaire:
Enregistrer un commentaire